CARMEL, Ind., Sept. 16, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: MBX) (“MBX Biosciences”), a clinical-stage biopharmaceutical ...

Zenas BioPharma, Inc. (“Zenas”), (Nasdaq: ZBIO) a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative ...

The Company has granted to the underwriters a 45-day option to purchase up to an additional 232,500 shares of common stock at the public offering price of $4.00 per share, less underwriting discounts ...

Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness today announced the pricing of its initial public offering of 1,500,000 ...

An Omani state-run oil and gas company says it will make an initial public offering of its exploration and production ...

BKV Corporation (“BKV”) today announced that it has launched the initial public offering of 15,000,000 shares of its common stock. The underwriters will have a 30-day option to purchase an additional ...

Kairos Pharma, Ltd. ("Kairos Pharma" or the "Company") (NYSE American: KAPA), a clinical stage biopharmaceutical company developing cancer therapeutics ...

Guardian Pharmacy Services, Inc. (“Guardian”) today announced the launch of its underwritten initial public offering of 6,750,000 shares of its Class A common stock pursuant to a registration ...

BKV Corporation (“BKV”) today announced that it has launched the initial public offering of 15,000,000 shares of its common stock. The underwriters will have a 30-day option to purchase an ...

New York, NY, Sept. 17, 2024 (GLOBE NEWSWIRE) -- YHN Acquisition I Limited (the "Company") announced today that it priced its initial public offering of 6,000,000 units at $10.00 per unit. The units ...

DENVER, September 16, 2024--(BUSINESS WIRE)--BKV Corporation ("BKV") today announced that it has launched the initial public offering of 15,000,000 shares of its common stock. The underwriters ...